Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Hong Kong
  4. Hong Kong Stock Exchange
  5. New Horizon Health Limited
  6. Summary
    6606   KYG6485S1021

NEW HORIZON HEALTH LIMITED

(6606)
  Report
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Hong Kong Stock Exchange
11/29/2021 11/30/2021 12/01/2021 12/02/2021 12/03/2021 Date
29.3 29.5 27.2 26.45 26 Last
342000 2410500 893100 437123 199000 Volume
-1.35% +0.68% -7.80% -2.76% -1.70% Change
Estimated financial data (e)
Sales 2021 178 M 27,9 M 27,9 M
Net income 2021 -322 M -50,5 M -50,5 M
Net cash position 2021 4 925 M 772 M 772 M
P/E ratio 2021 -30,4x
Yield 2021 -
Sales 2022 425 M 66,6 M 66,6 M
Net income 2022 -334 M -52,4 M -52,4 M
Net cash position 2022 4 564 M 716 M 716 M
P/E ratio 2022 -27,5x
Yield 2022 -
Capitalization 9 140 M 1 433 M 1 434 M
EV / Sales 2021 23,7x
EV / Sales 2022 10,8x
Nbr of Employees 557
Free-Float 63,5%
More Financials
Company
New Horizon Health Limited is a China-based investment holding company principally engaged in the research and development of screening products for colorectal cancer, cervical cancer and other types of cancer. The Company distributes its ColoClear, Pupu tube and other products to customers through its own network, contracted sales organisations (CSOs) and Internet sales or e-platform operated by healthcare clinics. 
More about the company
All news about NEW HORIZON HEALTH LIMITED
09/28NEW HORIZON HEALTH : Says Liver, Colon Cancer Screening Tests Improve Disease Detection; S..
MT
09/27New Horizon Health Limited Release of Preclinical Data for Livercleart A Multi-Omics Li..
CI
09/20NEW HORIZON HEALTH LIMITED(SEHK : 6606) added to S&P Global BMI Index
CI
08/21NEW HORIZON HEALTH ANNOUNCES 2021 IN : Revenue Increases 317% Year-on-year, Gross Profit M..
AQ
08/20New Horizon Health Limited Reports Unaudited Consolidated Earnings Results for the Six ..
CI
08/18Certain Class B Ordinary Shares of New Horizon Health Limited are subject to a Lock-Up ..
CI
08/18Certain Preferred Shares of New Horizon Health Limited are subject to a Lock-Up Agreeme..
CI
08/18Certain Class A Ordinary Shares of New Horizon Health Limited are subject to a Lock-Up ..
CI
08/10ThinkGeek Network Technology Files for Hong Kong IPO
MT
08/05Beijing Evercare Medical Files for Hong Kong IPO
MT
06/24MARKET CHATTER : SoftBank-backed EDDA Healthcare Eyeing $301 Million Hong Kong IPO
MT
06/22MARKET CHATTER : Medlive Technology Passes Hong Kong Listing Hearing
MT
06/15NEW HORIZON HEALTH : Eyes $30 Million Contribution in Diagnostic Technology Fund
MT
06/11New Horizon Health Limited Announces Principal Place of Business of the Company in Hong..
CI
06/10MARKET CHATTER : US-Based Biohaven Pharma Mulls Spinoff, Separate Listing of APAC Business..
MT
More news
News in other languages on NEW HORIZON HEALTH LIMITED
06/24DISCUSSIONS SUR LE MARCHÉ : EDDA Healthcare, soutenu par SoftBank, envisage une introducti..
02/18UPDATE/MÄRKTE ASIEN/Schanghai zum Wiederstart nur anfangs sehr fest
02/18MÄRKTE ASIEN/Schanghai zum Wiederstart nur anfangs sehr fest
02/18MÄRKTE ASIEN/Leichter - Schanghai zum Wiederstart fester
More news
Chart NEW HORIZON HEALTH LIMITED
Duration : Period :
New Horizon Health Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends NEW HORIZON HEALTH LIMITED
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 6
Last Close Price 21,27 CNY
Average target price 65,37 CNY
Spread / Average Target 207%
EPS Revisions
Managers and Directors
Ye Qing Zhu Chief Executive Officer & Executive Director
Yu Gao Chief Financial Officer & Joint Secretary
Yiyou Chen Chairman & Chief Scientific Officer
Ning Lu Chief Technology Officer
Danke Yu Independent Non-Executive Director
Sector and Competitors
1st jan.Capi. (M$)
NEW HORIZON HEALTH LIMITED0.00%1 433
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.67.89%23 009
BIOMÉRIEUX1.73%15 682
10X GENOMICS, INC.1.90%15 407
DIASORIN S.P.A.3.88%10 914
NATERA, INC.-10.47%8 188